Clinical characteristics and survival of systemic sclerosis patients with pulmonary hypertension and elevated wedge pressure: Observations from the PHAROS cohort

被引:7
作者
Lammi, Matthew R. [1 ]
Saketkoo, Lesley A. [2 ]
Gordon, Jessica K. [3 ]
Lauto, Paula [1 ]
Fagan, Karen [4 ]
Steen, Virginia D. [5 ]
机构
[1] Louisiana State Univ, Hlth Sci Ctr, Pulm Crit Care & Allergy Immunol, New Orleans, LA USA
[2] Tulane Univ, Sch Med, Sect Pulm Dis Crit Care & Environm Med, 1430 Tulane Ave, New Orleans, LA 70112 USA
[3] Hosp Special Surg, Dept Rheumatol, 535 E 70th St, New York, NY 10021 USA
[4] Univ S Alabama, Pulm & Crit Care, Mobile, AL USA
[5] Georgetown Univ, Div Rheumatol, Washington, DC USA
基金
美国国家卫生研究院;
关键词
diastolic dysfunction; pulmonary hypertension; scleroderma; systemic sclerosis; treatment; 6-MINUTE WALK TEST; VENTRICULAR DIASTOLIC DYSFUNCTION; HEART-FAILURE; OUTCOMES; RECOGNITION; PREVALENCE; PROGNOSIS; GRADIENT; DISEASE; MARKER;
D O I
10.1111/resp.13067
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background and objective: Systemic sclerosis (SSc) is a complex autoimmune disease commonly associated with pulmonary hypertension (PH). When associated with elevated pulmonary artery wedge pressure (PAWP), pulmonary artery pressure (PAP) is either inproportion (post-capillary PH) or higher than expected (combined PH) relative to the increased PAWP. Methods: Patients from the PHAROS registry (a prospective observational cohort of SSc-PH patients) who had mean PAP >= 25 and PAWP > 15 on right heart catheterization were stratified based on diastolic pressure gradient (DPG). Kaplan-Meier analysis was performed to compare survival and PH-related hospitalization. Baseline factors were compared between patients dying and those who survived using Cox regression analysis. Results: A total of 59 patients were included, of whom 21 (36%) patients were classified as combined PH and 38 (64%) had post-capillary PH. No baseline characteristics were significantly different between the two groups. There were no differences in survival or PHrelated hospitalization between the groups. The only baseline factor independently associated with death was lower 6-min walk distance (6MWD) (hazard ratio (HR): 1.33 per 25 m decrease, 95% CI: 1.11-1.59, P = 0.002). PH-specific medications were started during follow-up in significantly more patients in the combined PH group compared with the post-capillary group (86% vs 50%, P = 0.01). Conclusion: Outcomes were similar between SSc patients with post-capillary PH and combined pre- and post-capillary PH. 6MWD at baseline can predict risk for death in SSc patients with PH and an elevated PAWP. More patients with combined PH were started on PH-specific medications, and the clinical benefit of treating this subgroup specifically in SSc patients needs further exploration.
引用
收藏
页码:1386 / 1392
页数:7
相关论文
共 31 条
[1]   Relationship between left ventricular diastolic dysfunction and six minute walk test in patients with systemic sclerosis [J].
Akdogan, Ali ;
Kaya, Ergun B. ;
Sahin, Abdurrahman ;
Okutucu, Sercan ;
Yakut, Edibe ;
Kalyoncu, Umut ;
Aksoy, Hakan ;
Karadag, Omer ;
Calguneri, Meral ;
Tokgozoglu, Lale ;
Kiraz, Sedat ;
Ertenli, Ihsan .
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2011, 14 (04) :379-383
[2]   Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis [J].
Allanore, Y. ;
Meune, C. ;
Vonk, M. C. ;
Airo, P. ;
Hachulla, E. ;
Caramaschi, P. ;
Riemekasten, G. ;
Cozzi, F. ;
Beretta, L. ;
Derk, C. T. ;
Komocsi, A. ;
Farge, D. ;
Balbir, A. ;
Riccieri, V. ;
Distler, O. ;
Chiala, A. ;
Del Papa, N. ;
Simic, K. Pasalic ;
Ghio, M. ;
Stamenkovic, B. ;
Rednic, S. ;
Host, N. ;
Pellerito, R. ;
Zegers, E. ;
Kahan, A. ;
Walker, U. A. ;
Matucci-Cerinic, M. .
ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (01) :218-221
[3]   Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH):: randomised, double-blind, placebo-controlled trial [J].
Anand, I ;
McMurray, J ;
Cohn, JN ;
Konstam, MA ;
Notter, T ;
Quitzau, K ;
Ruschitzka, F ;
Lüscher, TF .
LANCET, 2004, 364 (9431) :347-354
[4]   A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST) [J].
Califf, RM ;
Adams, KF ;
McKenna, WJ ;
Gheorghiade, M ;
Uretsky, BF ;
McNulty, SE ;
Darius, H ;
Schulman, K ;
Zannad, F ;
HandbergThurmond, E ;
Harrell, FE ;
Wheeler, W ;
SolerSoler, J ;
Swedberg, K .
AMERICAN HEART JOURNAL, 1997, 134 (01) :44-54
[5]  
Ciurzynski M, 2008, KARDIOL POL, V66, P269
[6]   Heart diastolic dysfunction in patients with systemic sclerosis [J].
Ciurzynski, Michal ;
Bienias, Piotr ;
Irzyk, Katarzyna ;
Kostrubiec, Maciej ;
Szewczyk, Agnieszka ;
Demkow, Urszula ;
Siwicka, Maria ;
Kurnicka, Katarzyna ;
Lichodziejewska, Barbara ;
Pruszczyk, Piotr .
ARCHIVES OF MEDICAL SCIENCE, 2014, 10 (03) :445-454
[7]   SURVIVAL IN PATIENTS WITH PRIMARY PULMONARY-HYPERTENSION - RESULTS FROM A NATIONAL PROSPECTIVE REGISTRY [J].
DALONZO, GE ;
BARST, RJ ;
AYRES, SM ;
BERGOFSKY, EH ;
BRUNDAGE, BH ;
DETRE, KM ;
FISHMAN, AP ;
GOLDRING, RM ;
GROVES, BM ;
KERNIS, JT ;
LEVY, PS ;
PIETRA, GG ;
REID, LM ;
REEVES, JT ;
RICH, S ;
VREIM, CE ;
WILLIAMS, GW ;
WU, M .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (05) :343-349
[8]  
Deuschle K, 2011, CLIN EXP RHEUMATOL, V29, pS53
[9]   Five-year follow-up of left ventricular diastolic function in systemic sclerosis patients: Determinants of mortality and disease progression [J].
Faludi, Reka ;
Koelto, Gyoengyver ;
Bartos, Barbara ;
Csima, Georgina ;
Czirjak, Laszlo ;
Komocsi, Andras .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2014, 44 (02) :220-227
[10]   High prevalence of occult left heart disease in scleroderma-pulmonary hypertension [J].
Fox, Benjamin D. ;
Shimony, Avi ;
Langleben, David ;
Hirsch, Andrew ;
Rudski, Lawrence ;
Schlesinger, Robert ;
Eisenberg, Mark J. ;
Joyal, Dominique ;
Hudson, Marie ;
Boutet, Kim ;
Serban, Alexandrina ;
Masetto, Ariel ;
Baron, Murray .
EUROPEAN RESPIRATORY JOURNAL, 2013, 42 (04) :1083-1091